rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide
Clinical trial NCT03687957 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03687957
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-04
- Primary completion
- 2023-02-13
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.